Electra Private Equity PLC Board Appointment (5184P)

TIDMELTA

RNS Number : 5184P

Electra Private Equity PLC

18 November 2016

ELECTRA PRIVATE EQUITY PLC

18 November 2016

Board Appointment

The Board of Electra Private Equity PLC ("the Company") is pleased to announce the appointment of two non-executive directors of the Company: Linda Wilding with effect from 1 December 2016 and John McAdam with effect from 1 January 2017. Dr McAdam will also be appointed as the Senior Independent Director.

Linda Wilding has extensive experience in the private equity investment and healthcare sectors. Having qualified as a chartered accountant with Ernst & Young, she worked in the private equity division of Mercury Asset Management from 1989 to 2001, rising to the position of Managing Director. She has served as a non-executive director (including as Chairman) on the boards of a number of companies. She is currently a non-executive director of Imperial Innovations Group plc and UDG Healthcare plc. She is currently Chairman of the HgCapital Private Equity Valuation Committee, from which she intends to stand down in January 2017. She was a non-executive director and latterly Chair of Corin plc from 2006 to 2012. She has not held any other directorships of publicly quoted companies in the last five years.

John McAdam has extensive experience of senior leadership of global businesses in a wide range of industry sectors gained from his career with ICI and Unilever over more than 30 years and his other Board and advisor appointments. John joined Unilever PLC as a management trainee in 1974 and went on to hold a number of senior positions in Birds Eye Walls, Quest and Unichema before joining ICI plc, where he was Chief Executive until 2007. He is Chairman of Rentokil Initial plc and United Utilities plc and also a Non-Executive Director of Rolls-Royce Group plc. He was Senior Independent Director of J Sainsbury PLC until July 2016 and a Non-Executive Director of Sara Lee Corp (2008-14) and Severn Trent plc (2000-05). He has not held any other directorships of publicly quoted companies in the last five years.

There is no other information concerning Dr Wilding or Dr McAdam which is required to be disclosed pursuant to paragraph 9.6.13 R of the Listing Rules.

Neil Johnson, Chairman of Electra Private Equity, said:

"We are delighted that Linda Wilding and John McAdam will be joining the Electra Board. Linda brings a wealth of experience, in particular in the listed private equity sector. John's extensive career at a range of global companies will bring valuable industrial expertise to the board as we pursue our strategy of enhancing shareholder value. Both Linda and John are experienced and high-calibre individuals and they will make an immense contribution to the Board."

- ENDS -

For further information please contact:

Gill Ackers/Kim Fletcher

Brunswick Group LLP

020 7404 5959

[e-mail]

This information is provided by RNS

The company news service from the London Stock Exchange

END

BOAZMMMMLNKGVZM

(END) Dow Jones Newswires

November 18, 2016 02:01 ET (07:01 GMT)